SVB Leerink began coverage on shares of Myovant Sciences (NYSE:MYOV) in a report issued on Thursday morning, Price Targets.com reports. The firm issued a market perform rating and a $24.00 price objective on the stock.
A number of other brokerages also recently issued reports on MYOV. cut their price objective on Myovant Sciences from $30.00 to $24.00 and set a neutral rating for the company in a research report on Thursday, May 13th. Zacks Investment Research downgraded Myovant Sciences from a hold rating to a sell rating in a research report on Tuesday, August 10th. The Goldman Sachs....More>>>